Stock Events

AddLife AB 

€13.15
9
-€0.11-0.83% Friday 06:03

Statistics

Day High
13.15
Day Low
13.15
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
1.61B
P/E Ratio
162.25
Dividend Yield
0.33%
Dividend
0.04

Upcoming

Dividends

0.33%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
-33.55%
1Y Growth
N/A

Earnings

15JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
0.51
1.01
1.52
Expected EPS
1.3056174945599999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1AD1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Danaher
DHR
Mkt Cap180.39B
Danaher Corporation operates in the life sciences sector, offering similar products and services for research and clinical applications, directly competing with AddLife's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap203.97B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, closely aligning with AddLife's market.
Agilent Technologies
A
Mkt Cap38.45B
Agilent Technologies, Inc. supplies instruments, software, services, and consumables for the entire laboratory workflow, competing in the same space as AddLife AB.
Bio-Rad Laboratories
BIO
Mkt Cap8.45B
Bio-Rad Laboratories, Inc. produces and distributes products for a wide range of research and clinical diagnostic applications, making it a direct competitor to AddLife.
Waters
WAT
Mkt Cap17.96B
Waters Corporation designs, manufactures, and sells analytical standards and instruments, competing in the life sciences and diagnostics markets similar to AddLife.
Bruker
BRKR
Mkt Cap8.99B
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions that compete with AddLife's product offerings.
Resmed
RMD
Mkt Cap29.84B
ResMed Inc. specializes in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases, offering some products and services that compete with AddLife's.
Bio-Techne
TECH
Mkt Cap11.89B
Bio-Techne Corporation develops, manufactures, and sells biotechnology products and clinical calibrators and controls, competing in the biotech and clinical sectors like AddLife.
Qiagen NV
QGEN
Mkt Cap9.48B
QIAGEN N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, directly competing in the diagnostics and research market with AddLife.

About

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
Show more...
CEO
Mr. Fredrik Dalborg
Employees
2322
Country
SE
ISIN
SE0014401378
WKN
000A2P4TH

Listings